Month: April 2013

Cost Stock Update

                  Costco recently came out with its second-quarter fiscal 2013 results. The quarterly earnings of $1.10 per share beat the Zacks Consensus Estimate of $1.05, and surged 22.2% from 90 cents earned in the prior-year period.   Stock trading at 52 week high, recommend hold    

FFIV Stock Update

  April 5, the stock plunged almost 20%, from $90 to $73, as the company disappointed its investors, forecasting that its Q1 EPS will be much lower than the market expectations ($1.07 instead of $1.23). Despite the biggest appliance refresh in four years, F5 is still struggling with product revenue and clearly a concern. We …

FFIV Stock Update Read More »

$OMER update

In recent news, OMER presented at the 2013 Future Leaders in Biotech Industry in 04/2013. This stock has dropped below $4.00 this month. This stock is looking less like an opportunity. Important drugs are awaiting FDA approval, but I am not seeing enough supporting data that, even with new approvals, we will see a market …

$OMER update Read More »

$MO

Altria’s current share price is $35.48, close to it’s 52 week high of $36.29. Altria has outperformed the S&P by 60%. This company continues to show a strong balance sheet. As this company shares a major portion of its profits to shareholders and continues to diversify in new markets (smokeless products, cigars, wines etc.) I …

$MO Read More »

$MET Update

Operating performance continues to improve faster than analysts expect, and MetLife’s strong international operations should help build value in the coming years. Fourth-quarter performance was pretty solid: – Operating revenue rose nearly 12%, with broad growth across the business – Operating income, MetLife saw a strong 15% growth in core earnings – stronger than even …

$MET Update Read More »